REGEN-LAB
Regen Lab, a global commercial-stage medical technology company specializing in the research, development, registration, manufacturing and commercialization of proprietary tissue engineering products announces that its best-in-class medical devices REGENKIT®, CELLULAR MATRIX fig® and Arthrovisc® have obtained the CE certification under the EU Regulation 2017/745 on Medical Devices (MDR).
REGENKIT® is a preparation of Platelet-Rich Plasma (PRP), CELLULAR MATRIX fig®, a combination of PRP and Hyaluronic Acid (HA), and Arthrovisc®, HA filled syringes.
Based on the examination of its Quality Management System and Technical Documentation, these new CE certificates delivered to Regen Lab SA (EU authorized representative Regen Lab France SAS) by the notified body BSI are all valid for five years with a starting validity date on April 25, 2023, and an expiry date on April 24, 2028.
Imposed on all manufacturers and distributors operating in the European Union, the EU MDR 2017/745, applicable since May 26, 2021, in the European Union, is meant to mandatorily replace by 2028 the existing European Medical Device Directives (MDD 93/42/EEC). These EU regulations on medical devices aim at establishing a modern and more robust regulatory framework to protect public health and patient safety. This certification has considerably increased the amount of technical and clinical validation data required on medical devices across the EU, to address the need for a better traceability and transparency in safety.
In relation to the EU MDR certification of its products, Regen Lab successfully renewed its ISO13485:2016 and MDSAP certifications with a Quality Assurance System meeting the requirements of the European MDR EU 2017/745 Regulation in December 2022.
The certifications obtained reinforces Regenlab’s competitive position in the PRP market alone and in combination with HA.
Regen Lab autologous tissue engineering solutions are based on an extemporaneous preparation of PRP from the patient’s own blood and combined therapy (PRP combined with HA).
Regen Lab is a vertically integrated group with extensive R&D, regulatory and manufacturing expertise. To date, Regen Lab’s patented technologies* are available in over 90 countries worldwide and have been used to treat patients in various therapeutic areas (musculoskeletal, dermo-esthetics, wound care and urogenital) leading to the publication of over 200 clinical studies projects. The Company’s products are manufactured in the Group factories in Le Mont sur Lausanne (Switzerland), Brooklyn (New York, USA) since 2022, and in Les Ulis (Paris region, France) starting from Q3 of 2023.
More info about Medical Devices Regulation: https://ec.europa.eu/growth/single-market/european-standards/harmonised-standards/medical-devices_en
About Regen Lab
Based in Mont-sur-Lausanne, Switzerland, Regen Lab is a global commercial-stage medical technology company specialized in the research, development, registration, manufacturing and commercialization of proprietary tissue engineering solutions. The Company's solutions are commercialized in more than 90 countries and generated total revenues of €40 million in 2022. The core technology of the Company focuses on the design of solutions for autologous platelet-rich plasma (PRP) based procedures, consisting in reinjecting the patient's own platelets into tissue lesions in order to stimulate tissue healing. The Company's original medical devices, commercialized primarily under the RegenKit brand, have been CE marked EU-MDR 2017/745 and approved by FDA and CFDA and are routinely used by physicians worldwide for the treatment of a wide variety of main indications currently including joint osteoarthritis, tendinopathies and dermo-esthetics. The Company's products are manufactured in the Group factories in Le Mont-sur-Lausanne (Switzerland), New York (USA) since Q3 2022 and Les Ulis (Paris region, France) starting Q3 2023, which the Company has built to meet its anticipated increasing demand for its new products.
More info about RegenLab: https://www.regenlab.com
*For a list of Regenlab’s patents see: https://www.regenlab.com/patents
Regenkit®, Cellular Matrix fig®, Arthrovisc, Regenlab®, Regenplasma®, Regencell®, RegenACR®, THT® are registered or pending trademarks of Regen Lab SA or RegenLab USA LLC.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230515005412/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AB InBev Reports Third Quarter 2025 Results30.10.2025 07:05:00 CET | Press release
Consistent execution of our strategy delivered an EBITDA increase of 3.3% with margin expansion and low-single digit Underlying EPS growth Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029571716/en/ Regulated and inside information1 “Driven by the momentum of our megabrands and our innovation in balanced choices and Beyond Beer, our business delivered continued top- and bottom-line growth, even as we navigated a dynamic consumer environment. Given the progress we have made on our deleveraging and solid year-to-date financial results we have announced a new 6 billion USD share buyback program and an interim dividend.” – Michel Doukeris, CEO, AB InBev Revenue +0.9% Revenue increased by 0.9% in 3Q25 with revenue per hl growth of 4.8% and by 1.8% in 9M25 with revenue per hl growth of 4.5%. Reported revenue increased by 0.6% in 3Q25 to 15 133 million USD and d
Lake.com and Interhome Announce Strategic Partnership to Expand European Lakeside & Waterfront Vacation Rentals30.10.2025 07:00:00 CET | Press release
Lake.com, the vacation-rental marketplace built for life by the water, partnered with Interhome, one of Europe’s most established managers of holiday homes and apartments. The collaboration brings Interhome’s quality-checked villas, chalets, and apartments across 20+ European countries to Lake.com travelers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029035564/en/ Lake.com and Interhome announce partnership with 40,000 new vacation rentals. Today, Interhome’s professionally managed inventory becomes bookable on Lake.com, combining real-time rates and availability with Interhome’s local service offices for key handover, cleaning, and guest support. This marks Lake.com’s European expansion, deepening selection in high-demand lakeside and coastal destinations. Lake.com’s integration with Interhome adds more than 40,000 holiday homes—from Italy’s Lake Garda and Como to Austria’s Salzkammergut, Switzerland’s Lakes Lucerne
Yokogawa to DeliverIntegrated Control Systems for Urban Infrastructure in Green Riyadh Project30.10.2025 02:00:00 CET | Press release
- Contributing to a national urban afforestation initiative that aims to transform the Saudi capital into one of the world's most livable cities - Yokogawa Electric Corporation (TOKYO: 6841) announces that its subsidiary, Yokogawa Saudi Arabia, has been awarded a contract by the Royal Commission for Riyadh City to provide the necessary systems and services for the main command and control center of the Green Riyadh project*. Led by the Government of Saudi Arabia, this national initiative is a key element of Saudi Vision 2030. Its objective is to transform Riyadh into one of the world’s most livable cities through urban greening, enabling residents to lead healthier and more sustainable lives. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029727530/en/ Riyadh, Saudi Arabia The project will plant 7.5 million trees across parks, public facilities, healthcare centers, and roads by 2030, increasing green space per capita from
R2 Joins Ant International to Expand Credit Access for SMEs in LATAM30.10.2025 01:04:00 CET | Press release
The investment will enable both companies to integrate their expertise to improve credit access for small and medium-sized enterprises (SMEs) in a region facing a credit gap of over US$1 trillion Ant International, a leading global digital payment, digitisation, and financial technology provider, today announced a strategic investment in R2, the leading embedded lending infrastructure company in Latin America (LATAM), to expand access to credit for SMEs across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029918704/en/ From left to right: Roger Larach, Co-Founder and Chief Executive Officer, R2 | Quan Yu, General Manager of Global Credit Services, Ant International | Roger Teran, Co-Founder and Chief Data Officer, R2 R2 enables digital platforms to offer financing solutions quickly and securely through an API-based, end-to-end white-labeled experience. This allows merchants to easily access capital through th
Axelspace Signs MoUs with Two African Organizations to Address Social Challenges through the Utilization of Satellite Data29.10.2025 21:57:00 CET | Press release
Collaborating with Partners in Ghana and Kenya to Develop and Implement Tailored Solutions Axelspace Corporation (“Axelspace”), which develops and operates microsatellites and conducts business to promote a society where space is accessible to people around the world, is pleased to announce the memorandum of understandings (MoUs) with two governmental organizations of African countries on cooperation for addressing social challenges through the utilization of satellite-based Earth observation (EO) data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029793600/en/ Genevieve Edna Apaloo, Ambassador Extraordinary and Plenipotentiary of the Republic of Ghana to Japan and Yuya Nakamura, President and CEO, Axelspace at the signing ceremony on stage at NIHONBASHI SPACE WEEK 2025 Axelspace signed MoUs individually with the Ghana Space Science and Technology Institute (GSSTI) of the Republic of Ghana, and the Regional Centre for M
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom